Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Syndicate Forecasts

7 Jun 2016 07:00

RNS Number : 3556A
Helios Underwriting Plc
07 June 2016
 

7th June 2016

 

 

Helios Underwriting plc

("Helios" or the "Company")

 

 

Quarterly Syndicate Mid Point Forecasts

 

Helios announces the current mid point forecasts in respect of its portfolio of syndicate capacity for the 2014 and 2015 years of account based on 1st quarter 2016 results.

 

 

 

 

 

Year of Account

 

 

 

 

2014

2015

2016

 

 

 

 

£m

£m

£m

Capacity - Position as at 1st Jan 2016

 

 

29.2

26.8

28.1

Retained

 

 

 

14.3

10.6

8.4

Reinsured

 

 

 

14.9

16.2

19.7

 

 

 

 

 

 

 

Capacity acquired since 1st Jan 2016

 

 

 

 

 

Retained

 

 

 

5.2

4.5

1.4

Reinsured

 

 

 

-

-

3.2

 

 

 

 

 

 

 

Capacity - Position as at 30th May 2016

 

 

 

 

Retained

 

 

 

19.5

15.1

9.8

Reinsured

 

 

 

14.9

16.2

22.9

 

 

 

 

34.4

31.3

32.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mid point forecast at 1st Jan

 

8.93%

N/A

 

Current Mid point forecast

 

 

9.22%

6.98%

N/A

 

 

 

 

 

 

Lloyds Market Average

 

 

5.96%

4.25%

 

Helios outperformance

 

 

3.26%

2.73%

 

 

 

 

 

 

 

Notes

 

1) The table shows the movement in capacity as result of acquisitions made since 1st Jan 2016 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers.

2) The mid point forecasts as of 1st quarter 2016 have been aggregated at syndicate level from estimates supplied by Managing Agents

3) The impact on Helios will be as follows:

a. The additional capacity acquired on the open years will make a contribution to the earnings of Helios although part of the result will have been earned in prior years or will be treated as pre-acquisition profits. 

b. The increase in the mid point estimates on the retained capacity will be recognised in the Helios income statement this year.

c. The overall improvement in the result will be received by Helios in cash when the profits are distributed after the close of the year of account.

 

 

For further information please contact:

Helios

Nigel Hanbury - Chief Executive 020 7863 6655 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer    07754 965917

 

Stockdale Securities    020 7601 6100

Robert Finlay

Rose Ramsden

 

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £32 million of capacity for the 2016 account. The portfolio provides a good spread of classes of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUGUQUPQGQQ
Date   Source Headline
18th Jan 20217:00 amRNSAppointment of Financial Adviser
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSMaterial Capacity Increase
30th Nov 20209:57 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSHolding(s) in Company
26th Nov 20203:40 pmRNSResult of GM, TVR and Directors' Participations
24th Nov 20207:00 amRNSResult of Open Offer
19th Nov 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
2nd Nov 20207:00 amRNSPlacing, Subscription, Open Offer & Acquisitions
7th Oct 20207:00 amRNSProposed Fundraising
25th Sep 20207:00 amRNSHalf-year Report
17th Aug 20207:00 amRNSQuarterly Syndicate Mid-Point Forecasts
10th Aug 20207:00 amRNSUpdate on Capacity and Growth Plans
25th Jun 202012:38 pmRNSResult of AGM
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 202012:28 pmRNSHolding(s) in Company
1st Jun 20207:30 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSFinal results for the year ended 31 December 2019
30th Mar 20207:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20207:00 amRNSCapacity Update and Transaction in Own Shares
13th Dec 20197:00 amRNSAcquisition
18th Nov 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
7th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20199:39 amRNSReplacement- Transaction in Own Shares
2nd Sep 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Aug 20194:28 pmRNSHolding(s) in Company
12th Aug 20197:00 amRNSProposed Ordinary Share repurchases
19th Jul 20198:47 amRNSHolding(s) in Company
16th Jul 20191:00 pmRNSResult of Meeting
28th Jun 20193:13 pmRNSResult of AGM
13th Jun 20197:00 amRNSChange of Adviser
13th Jun 20197:00 amRNSFundraising, Acquisition, Waiver & Notice of GM
31st May 20197:00 amRNSFinal results for the year ended 31 December 2018
30th May 20192:14 pmRNSDirector's Disclosure
17th May 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
10th May 20199:30 amRNSTrading Update
29th Mar 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20197:00 amRNSDirector Dealing
23rd Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20192:36 pmRNS2019 Capacity Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.